Evidence map›Paper›PMID 23001720›Full record

ArticleArchives of virology2013

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.

Jens H Kuhn, Yiming Bao, Sina Bavari, Stephan Becker, Steven Bradfute, J Rodney Brister, Alexander A Bukreyev, Kartik Chandran, Robert A Davey, Olga Dolnik and 27 more

2 registry-linked trialsAbstract readNews
In one paragraph

Article in Archives of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02231866 phase1completednot on this mapstarted 2014, after this paper: background citation

VRC 207: A Phase I/1b, Open-Label, Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccines, VRC-EBOADC069-00-VP (cAd3-EBO) and VRC-EBOADC076-00-VP (cAd3-EBOZ), in Healthy Adults

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2014 to 2017Enrolled143ConditionsHealthy Adult Immune Responses to VaccineArmsVRC-EBOADC069-00-VP, VRC-EBOADC076-00-VP
NCT02485912 phase1completednot on this mapstarted 2015, after this paper: background citation

A Phase Ib Safety and Immunogenicity Clinical Trial of Heterologous Prime-boost Immunisation With ChAd3-EBO Z and MVA-EBO Z in Healthy Senegalese Adult Volunteers Aged 18-50 Years.

TypeinterventionalSponsorUniversity of OxfordRan2015 to 2016Enrolled40ConditionsEbola Virus DiseaseArmsChAd3-EBO Z, MVA-EBO Z
3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Article
  2. Physics of Protein Aggregation in Normal and Accelerated Brain Aging.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  3. Marburg Virus Disease: A Narrative Review.Health science reports · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  15. Review
  16. Alphaherpesvirus Genomics: Past, Present and Future.Current issues in molecular biology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Development of an antibody cocktail for treatment of Sudan virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Jens H Kuhn
Yiming Bao
Sina Bavari
Stephan Becker
Steven Bradfute
J Rodney Brister
Alexander A Bukreyev
Kartik Chandran
Robert A Davey
Olga Dolnik
John M Dye
Sven Enterlein
Lisa E Hensley
Anna N Honko
Peter B Jahrling
Karl M Johnson
Gary Kobinger
Eric M Leroy
Mark S Lever
Elke Mühlberger
Sergey V Netesov
Gene G Olinger
Gustavo Palacios
Jean L Patterson
Janusz T Paweska
Louise Pitt
Sheli R Radoshitzky
Erica Ollmann Saphire
Sophie J Smither
Robert Swanepoel
Jonathan S Towner
Guido van der Groen
Viktor E Volchkov
Victoria Wahl-Jensen
Travis K Warren
Manfred Weidmann
Stuart T Nichol

Funding

Integrated Research Facility at Fort DetrickZIDAI009006 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI COE, LINDA · 2009 to 2018
$341.7M
Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Dennis A Bente · 2011 to 2026
$208.8M
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERSZIAAI001025 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JOHNSON, REED · 2009 to 2018
$14.1M
Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001025NIAID NIH HHS UC7 AI094660
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Terminology as TopicAnimalsClassificationFiloviridaeFiloviridae InfectionsHumans

Identifiers

PMID23001720
PMCPMC3535543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.